MedTrace Logo

Procoagulant Effects of Hyperglycemia After Acute Stroke: A Pilot Study

NCT00373269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2017-02-27

Study results available
· View outcomes & findings →

Summary

Between twenty and fifty percent of people who have acute stroke have hyperglycemia (high blood sugar) with it. The purpose of this study is to examine the relationships between diabetes mellitus, hyperglycemia,whole blood tissue factor procoagulant activity (TF-PCA) and plasma factorVIIa (FVIIa) in ten patients with type 2 diabetes mellitus and 11 non-diabetic patients at baseline and 6, 12, 24, and 48 hours (h) after presentation for acute stroke.

Conditions

Sponsors & Collaborators

  • Temple University

    lead OTHER

Principal Investigators

  • Nina T Gentile, MD · Temple University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2005-11-30
Completion
2005-11-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00373269 on ClinicalTrials.gov